ABSTRACT 3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, the key regulatory enzyme of the isoprenoid pathway, was found to be predominantly microsomal in Ochromonas malhamensis, a chrysophytic alga. Detection of HMG-CoA reductase requires the presence of 1% bovine serum albumin during cell homogenization, and the activity is stimulated by the presence of Triton X-100. The enzyme has a pH optimum of 8.0 and an absolute requirement for NADPH. When grown in 10 micromolar mevinolin, a competitive inhibitor of HMG-CoA reductase, 0. malhamensis shows a 10-to 15-fold increase in HMG-CoA reductase activity (after washing) with little or no effect on cell growth rate. Cultures can be maintained in 10 micromolar mevinolin for months. 0. malhamensis produces a large amount (1% dry weight) of poriferasterol, a product of the isoprenoid pathway. The addition of 10 micromolar mevinolin initially blocked poriferasterol biosynthesis by >90%; within 2 days the rate of synthesis returned to normal levels. Immediately after mevinolin was washed from the 2-day culture, there was a transient 2.5-fold increase in the rate of poriferasterol biosynthesis. The rate of poriferasterol biosynthesis and the level of HMG-CoA reductase activity both fell to control levels within hours.
the biochemical and metabolic mechanisms that control the rate of synthesis of isoprenoid end products in plants. In mammalian tissue the isoprenoid pathway is regulated at the level of the gene and at the level of the enzyme. Steroids, for example, act in a negative-feedback loop to drastically lower the amount ofmRNA available for the synthesis of HMG-CoA reductase (13) . Other, shorter term, regulatory mechanisms control the rate of carbon flow by phosphorylating the enzyme to an inactive form via a protein kinase, and dephosphorylating the enzyme to an active form via an independent phosphorylase (for review, Ref. 11 ). The approach used in this study was to increase the activity of HMG-CoA reductase in vivo with the use of the competitive inhibitor, mevinolin, and to determine the degree of enhancement of short-term end-product synthesis after release from mevinolin inhibition.
We chose to study HMG-CoA reductase and the control of sterol biosynthesis in a single-cell plant system, Ochromonas malhamensis. This chrysophycean unicellular alga produces a large amount of sterol (-1% dry weight), of which 98% is poriferasterol ( 16) . The diversion of fixed carbon into one major product in this organism simplified considerably the analysis of '4C-labeled isoprenoid products. In addition, 0. malhamensis lacks a cell wall, which facilitates the extraction and analysis of sterol content, as well as controlled cell homogenization and generation of organellar fractions.
The isoprenoid pathway in plants is the source of a variety of significant products, including plant hormones, low mol wt volatiles, vitamins A and D, #-carotene, steroids, and natural rubber. The pathway in mammalian tissue is tightly regulated at the entry point, where HMG-CoA2 is reduced to MVA. The enzyme that catalyzes this step, HMG-CoA reductase (mevalonate: NADP oxidoreductase, EC 1.1.1.34) has been extensively studied in mammalian systems and is assumed to be the major rate-limiting enzyme in sterol biosynthesis (for review, see Refs. 5 and 21). In addition, HMG-CoA reductase provides nonsterol intermediates required for DNA replication and other cell functions (for review, see Ref. 14) . Within the last 10 years, HMGCoA reductase has been identified and studied in several higher plant systems (for review, see Ref. 15 ).
The objective of this research is to develop a system to study Cultures were inoculated with various concentrations of mevinolin, and aliquots were removed at specified time points for measurement of cell density, microsomal HMG-CoA reductase, and rate of sterol biosynthesis. In some experiments, the effect of removing mevinolin from the cultures on the above parameters was examined. Cells were pelleted by centrifugation ( (8, 17, 23 ). Of the compounds tested for their ability to stabilize HMG-CoA reductase activity during homogenization, only BSA at concentrations >1 % (w/v) led to a consistent and pronounced increase in recovered enzyme activity. BSA has been reported to enhance the HMG-CoA reductase activity of sweet potato root by 50%; it apparently prevents labilization of HMG-CoA reductase caused by degradation of microsomal phospholipids (23) . This might also be the case in 0. malhamensis. In addition, the BSA might serve to prevent structural and functional changes in membranes or proteins induced by the free fatty acids (JH Golbeck, unpublished data) and/or chlorosulfolipids (20) released during homogenization of 0. malhamensis. Inclusion of 1% PVPP, 0.1 TIU/ml Aprotinin, 100 M leupeptin, or 1 mM phenylmethylsulfonyl fluoride, either singly or in combination during homogenization of 0. malhamensis, resulted in no improvement of recovered activity.
Subcellular fractions were prepared from 0. malhamensis by stepwise centrifugation to localize the HMG-CoA reductase activity. The microsomal pellet contained 90% ± 7 (n = 12) of the HMG-CoA reductase activity with a specific activity of 5.8 ± 4.5 (n = 33) nmol MVA/mg protein-h; the remaining activity was located in the low-speed pellet. No HMG-CoA reductase activity was found in the final supernatant fraction. The enzyme is primarily microsomal in pea seedling (9) and radish seedling (4) but predominantly mitochondrial in uninfected sweet potato root (22) and chloroplastic in Nepeta cataria leaves (12) .
As in all other eukaryotic systems studied, microsomal HMGCoA reductase from 0. malhamensis has an absolute and specific requirement for NADPH. NADPH, or in the absence of pyridine nucleotides.
The effect of pH on HMG-CoA reductase is shown in Figure  1 . The enzyme shows a sharp optimum at pH 8.0 with a large decline in activity above and below the peak. This pH optimum is somewhat higher than that reported for other plant systems which typically falls between 6.8 and 7.5 (15) . Addition of 10 mM CaCl2, 10 mM MgCl2, or 10 mM EDTA had no effect on the specific activity of HMG-CoA reductase. BSA, although required during cell homogenization, had no effect when added to the assay mixture.
There was approximately 60% more activity measured in the presence of 0.5 to 1.0% Triton X-100 than in its absence. The stimulatory effect of Triton X-100 on microsomal HMG-CoA reductase was observed in freshly prepared enzyme suspensions and in suspensions that had been frozen and thawed before assay. Triton X-100 also enhances the activity of HMG-CoA reductase in sweet potato root (24) .
No stimulation of reductase activity from freeze-thawed 0. malhamensis microsome suspensions was observed after a preincubation at 30°C before assay. Thus, there is no evidence for reversible cold inactivation in this system, as is the case with soluble rat liver HMG-CoA reductase (18) .
Effect of Mevinolin on Cell Growth. Mevinolin, a fungal metabolite similar in structure to HMG-CoA, has been shown to be a highly specific competitive inhibitor of HMG-CoA reductase from animal (1) and plant (2) tissues. Mammalian cells exposed to mevinolin are induced to synthesize additional HMGCoA reductase to compensate for the enzyme inactivated by the inhibitor (1) . This compound, as well as structurally similar compactin, has been exploited by investigators in a wide variety of systems to study aspects of the regulation of mammalian cholesterol biosynthesis (10), chloroplast biogenesis (19), plant growth (3, 1 1), and plant sterol and pigment accumulation (3).
Mevinolin was added to log phase cultures of 0. malhamensis in concentrations ranging from 10 to 200 Mm, and growth was monitored for a 3-d period (Fig. 2) . Cultures grown in 10, 50, and 100 AM mevinolin exhibited logarithmic growth, but at progressively slower rates with increasing mevinolin concentra- tion (Fig. 2) . No lag period in growth was observed after mevinolin was added, and the size distribution of the cells grown in 10 to 100 Mm mevinolin did not vary measurably from control cultures. Cultures could be passaged in the presence of 10 gM mevinolin for over 6 months with little or no detectable effect on growth rates. There was no growth of 0. malhamensis in the presence of 200 AM mevinolin (Fig. 2) .
Effect of Mevinolin on HMG-CoA Reductase Activity. HMGCoA reductase activity in 0. malhamensis, assayed after washing the cells free of inhibitor, increases in response to the presence of the inhibitor mevinolin (Table I) . Cultures grown for 2 to 3 d in the presence of 10 or 50 gM mevinolin showed the largest increase (10-to 16-fold) in microsomal HMG-CoA reductase activity relative to control cultures. Cells grown in 100 gM mevinolin showed a somewhat smaller increase in HMG-CoA reductase activity relative to control cultures (about 7-fold) and had pronouncedly slower growth rates than did the controls (Table I; Fig. 2 ). The level of microsomal HMG-CoA reductase activity was also examined after prolonged culture in the presence of 10 Mm mevinolin. After 23 and 100 d ofsubculture and growth in the continuous presence of 10 Mm mevinolin, treated cultures had 3 to 4 times more microsomal HMG-CoA reductase activity after washing than did the control cultures.
Effect of Mevinolin on Poriferasterol Biosynthesis. The effect of mevinolin on the biosynthesis of poriferasterol was examined in log-phase cultures of 0. malhamensis shortly after the introduction of 10 and 100 AM mevinolin and after 2 d of growth in 10 and 100 ,M mevinolin. Total '4C incorporation into the ethersoluble fractions of treated cultures was reduced by about 35 to 55% compared with controls (data not shown). A significant proportion of this inhibition resulted from a dramatic reduction in the amount of poriferasterol labeling (Table II) Table 1 . E,ffect ofMevinolin on Cell Growth and on the Specific Activity ofHMG-CoA Redtlase in 0. malhamensis An inoculum of 0. malhamensis was delivered to shake flasks containing 0 Mm (control), 10, 50, or 100 Mm mevinolin in growth medium and incubated at 30°C. For long-term experiments, cells were diluted into fresh medium ±10 Mm mevinolin every 3 to 4 d. Cell number was monitored at 24-h intervals throughout the exposure period. At the end of the indicated treatment period, cells were harvested and rinsed, microsomes were prepared, and HMG-CoA reductase was determined radiochemically. a Relative rate of growth is defined as the specific growth rate (Mu) of the control culture divided by the specific growth rate of the treated culture. M = (I nx -I nx)/t, where x = final cell density, xo = initial cell density, and t = elapsed time. b Relative reductase activity is defined as the specific activity of treated culture divided by the specific activity of the control culture. A culture exposed to 10 Mm mevinolin for 48 h was rinsed and resuspended in mevinolin-free medium; a similarly grown culture containing no inhibitor was identically processed and served as a control. Two consecutive ['4C]acetate time-course incorporation experiments were conducted with 20-ml aliquots removed from the original cultures 30 min after the rinse (0.5, 1, 2, and 4 h time points), and 10 h after the rinse (10.5 h time point). HMG-CoA reductase activity was determined at the beginning of each incorporation experiment, i.e. 0.5 and 10 h. Initially, the HMG-CoA reductase activity in mevinolin-treated cultures was 13-fold greater than in the control cultures (Table III) . After removal of the inhibitor, the HMG-CoA reductase activity fell to control values within hours. Immediately after mevinolin was removed by washing, the rate of ['4C]acetate incorporation into poriferasterol was 2.5-fold greater per cell than in the control. However, this ratio declined steadily with time, so that by the beginning of the 10-h incorporation experiment and thereafter (data not shown), no significant difference in 14C-sterol/cell was evident. These results were in temporal, though not quantitive, agreement with the enzyme data: the rate of carbon flow is clearly related to enzyme activity although the magnitude of the increase in the rate of poriferasterol biosynthesis was lower than the absolute increase in HMG-CoA reductase activity.
Relative
This quantitative discrepancy could be due to the presence of residual mevinolin following washes or to insufficient in vivo levels of HMG-CoA. Alternatively, a rapid mechanism for inactivating HMG-CoA reductase in vivo may be present such as the phosphorylation-dephosphorylation system operative in mammalian systems (5) . The possibility also exists that HMGCoA reductase may not be the rate determining step when it is present at high levels. It is well known (10) that no intermediates accumulate in the pathway from mevalonic acids to steroids, implying that none of the intermediate enzymic steps are rate limiting under normal circumstances. However, when HMGCoA reductase levels are elevated, as in this study, other secondary control points may become rate limiting and the rate of carbon flow to steroids may not be accurately reflected in the levels of HMG-CoA reductase. The ability to raise HMG-CoA reductase activity in a plant system therefore offers the possibility for studying secondary control points within the steroid pathway under conditions where HMG-CoA reductase may not be the rate-limiting enzyme. Indeed, deregulation of selected secondary control points may be desirable for shunting carbon to a small number of significant products such as ,-carotene, vitamins, and steroids.
This research demonstrates that an important enzyme in the isoprenoid pathway operates under strict metabolic control in a unicellular plant system. The transient increase in poriferasterol biosynthesis indicates that in the short term, carbon flow through the isoprenoid pathway in 0. maihamensis is related to the level of HMG-CoA reductase. Therefore, the potential exists for deregulating this enzymic step so that increased rates of synthesis of isoprenoid products can be achieved. Further research must also take into account secondary metabolic controls exerted at other points on the pathway and the availability of carbon in the form of HMG-CoA at the entry point to the pathway. 
